NDC00469-7253-02 — CEFTIZOXIME INJECTION

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC00469-7253-02: CEFTIZOXIME INJECTION.

The CEFTIZOXIME INJECTION is a the manufacturer industrial component. Key specifications include physical_form: POWDER, administration: INTRAVENOUS, primary_container_type: VIAL, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 2.000 GRAMS OF ACTIVE INGREDIENT G, active_medicament_medicinal_strength: 2.00 GRAMS CEFTIZOXIME EQUIVALENT G. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-185-3299, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC00469-7253-02

NSN: 6505-01-185-3299
FSC: 6505 — Drugs and Biologicals
CAGE: 39832 — ASTELLAS PHARMA US, INC. (USA)

SPECIFICATIONS

physical_form	POWDER
administration	INTRAVENOUS
primary_container_type	VIAL
medical_designation_and_grade	UNITED STATES PHARMACOPEIA
primary_container_content_quantity	2.000 GRAMS OF ACTIVE INGREDIENT G
active_medicament_medicinal_strength	2.00 GRAMS CEFTIZOXIME EQUIVALENT G
part_name_assigned_by_controlling_agency	CEFTIZOXIME SODIUM STERILE USP POWDER FORM 2GM VIAL
NSN	6505-01-185-3299

COMPONENT DIAGRAM

KEY FEATURES

•

ADMINISTRATION: INTRAVENOUS

•

PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT G

•

MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA

•

PRIMARY CONTAINER TYPE: VIAL

•

PHYSICAL FORM: POWDER

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.00 GRAMS CEFTIZOXIME EQUIVALENT G

TECHNICAL CHARACTERISTICS

ADMINISTRATION	INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY	2.000 GRAMS OF ACTIVE INGREDIENT G
MEDICAL DESIGNATION AND GRADE	UNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPE	VIAL
PHYSICAL FORM	POWDER
PART NAME ASSIGNED BY CONTROLLING AGENCY	CEFTIZOXIME SODIUM STERILE USP POWDER FORM 2GM VIAL
ACTIVE MEDICAMENT MEDICINAL STRENGTH	2.00 GRAMS CEFTIZOXIME EQUIVALENT G

SUBSTITUTES & CROSS-REFERENCES 2

CEFIZOXReference document

Same NSN cross-reference

Reference document — Secondary reference

NDC57317-0253-02Reference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

HAZMAT per U.S. Government catalogShelf-life managedAcquisition advice: Terminal item — stock exhausted; no further procurementNo demilitarization required

Ready to buy NDC00469-7253-02?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC00469-7253-02?

NDC00469-7253-02 is a CEFTIZOXIME INJECTION.

What parts can replace NDC00469-7253-02?

There are 2 known substitutes for NDC00469-7253-02: CEFIZOX, NDC57317-0253-02. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC00469-7253-02?

NDC00469-7253-02 is cataloged in the U.S. Government catalog under NSN 6505-01-185-3299. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC00469-7253-02 — CEFTIZOXIME INJECTION

Request a Quote — NDC00469-7253-02